Tissue Regenix Group plc provided earnings guidance for the full year ended 31 December 2019. The Group expects to deliver revenue and EBITDA in line with its revised expectations as reported on 17 October 2019. Revenue is anticipated to be £13 million (2018: £11.6 million), representing an annual increase of 12%.